<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01540201</url>
  </required_header>
  <id_info>
    <org_study_id>2011-12-033-002</org_study_id>
    <nct_id>NCT01540201</nct_id>
  </id_info>
  <brief_title>The Effect of Different I:E Ratio on Gas Exchange of Patients Undergoing One-lung Ventilation for Lung Surgery</brief_title>
  <official_title>The Effect of Different I:E Ratio on Gas Exchange of Patients Undergoing One-lung Ventilation for Lung Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pulmonary gas exchange disturbance is a common anesthetic problem during one-lung ventilation
      (OLV) for thoracic surgery. The inverse-ratio ventilation (IRV), which prolongs the
      inspiratory time greater than expiratory time, can be applied for adult respiratory distress
      syndrome. The effect of IRV is to improve gas-exchange status by increasing mean airway
      pressure and alveolar recruitment. We tried to evaluate the effect of IRV during OLV with
      lung protective strategy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pulmonary gas exchange disturbance is a common anesthetic problem during one-lung ventilation
      (OLV) for thoracic surgery. Continuous positive airway pressure or positive end-expiratory
      pressure are usually applied to improve this disorder including hypoxia, but these methods
      are not enough. The inverse-ratio ventilation (IRV), which prolongs the inspiratory time
      greater than expiratory time, can be applied for adult respiratory distress syndrome. The
      effect of IRV is to improve gas-exchange status by increasing mean airway pressure and
      alveolar recruitment. The application of IRV during OLV has not been performed to our
      knowledge, and there is a possibility of IRV to improve oxygenation during OLV. There is a
      possibility of increase of auto-PEEP, or air trapping in subjects with chronic obstructive
      pulmonary disease, but this kind of auto-PEEP can be overcome by external PEEP. Therefore, we
      tried to evaluate the effect of IRV during OLV with lung protective strategy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>arterial CO2 partial pressure</measure>
    <time_frame>10 minutes after induction of general anesthesia</time_frame>
    <description>arteial CO2 partial pressure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>arterial CO2 partial pressure</measure>
    <time_frame>30 minutes after start of one-lung ventilation</time_frame>
    <description>arteial CO2 partial pressure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>arterial CO2 partial pressure</measure>
    <time_frame>60 minutes after start of one-lung ventilation</time_frame>
    <description>arteial CO2 partial pressure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>arterial CO2 partial pressure</measure>
    <time_frame>15 min after restart of TLV</time_frame>
    <description>arteial CO2 partial pressure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>arterial CO2 partial pressure</measure>
    <time_frame>1 hour after the end of surgery</time_frame>
    <description>arteial CO2 partial pressure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>arterial O2 partial pressure</measure>
    <time_frame>10 min after induction, 30 and 60 min after start of one-lung ventilation, 15 min after restart of two-lung ventilation, 1 hour after the end of surgery</time_frame>
    <description>arterial O2 partial pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean airway pressure</measure>
    <time_frame>10 min after induction, 30 and 60 min after start of one-lung ventilation, 15 min after restart of two-lung ventilation</time_frame>
    <description>Mean airway pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tidal volume (exhaled)</measure>
    <time_frame>10 min after induction, 30 and 60 min after start of one-lung ventilation, 15 min after restart of two-lung ventilation</time_frame>
    <description>tidal volume (exhaled)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hemodynamic parameters</measure>
    <time_frame>10 min after induction, 30 and 60 min after start of one-lung ventilation, 15 min after restart of two-lung ventilation</time_frame>
    <description>systolic/ diastolic blood pressure, heart rate, mean blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>end-tidal CO2 partial pressure</measure>
    <time_frame>10 min after induction, 30 and 60 min after start of one-lung ventilation, 15 min after restart of two-lung ventilation</time_frame>
    <description>end-tidal CO2 partial pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>respiratory compliance</measure>
    <time_frame>10 min after induction, 30 and 60 min after start of one-lung ventilation, 15 min after restart of two-lung ventilation</time_frame>
    <description>Dynamic compliance, Static compliance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dead space</measure>
    <time_frame>10 min after induction, 30 and 60 min after start of one lung ventilation, 15 min after restart of two-lung ventilation</time_frame>
    <description>physiologic dead space / tidal volume (VD/VT)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>work of breathing</measure>
    <time_frame>10 min after induction, 30 and 60 min after start of one-lung ventilation, 15 min after restart of two-lung ventilation</time_frame>
    <description>work of breathing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>peak inspiratory pressure</measure>
    <time_frame>10 min after induction, 30 and 60 min after start of one-lung ventilation, 15 min after restart of two-lung ventilation</time_frame>
    <description>peak inspiratory pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>plateau pressure</measure>
    <time_frame>10 min after induction, 30 and 60 min after start of one-lung ventilation, 15 min after restart of two-lung ventilation</time_frame>
    <description>plateau pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>positive end-expiratory pressure</measure>
    <time_frame>10 min after induction, 30 and 60 min after start of one-lung ventilation, 15 min after restart of two-lung ventilation</time_frame>
    <description>positive end-expiratory pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>minute ventilation</measure>
    <time_frame>10 min after induction, 30 and 60 min after start of one-lung ventilation, 15 min after restart of two-lung ventilation</time_frame>
    <description>minute ventilation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">110</enrollment>
  <condition>Lung Cancer</condition>
  <condition>One Lung Ventilation</condition>
  <condition>Gas Exchange</condition>
  <condition>Inverse-ratio Ventilation</condition>
  <arm_group>
    <arm_group_label>1:2 group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>conventional I:E ratio group, inspiratory time : expiratory time = 1:1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1:1 group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>inspiratory time : expiratory time = 1:1</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Conventional I:E ratio</intervention_name>
    <description>conventional I:E ratio of 1:2 is applied. Ventilator : Datex-Ohmeda Aestiva/5 速 model</description>
    <arm_group_label>1:2 group</arm_group_label>
    <other_name>I:E ratio of 1:2</other_name>
    <other_name>Ventilator : Datex-Ohmeda Aestiva/5 速 model</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>I:E = 1:1 ratio</intervention_name>
    <description>I:E ratio of 1:1 is applied Ventilator : Datex-Ohmeda Aestiva/5 速 model</description>
    <arm_group_label>1:1 group</arm_group_label>
    <other_name>I:E ratio of 1:1</other_name>
    <other_name>Ventilator : Datex-Ohmeda Aestiva/5 速 model</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing elective lung lobectomy surgery.

          -  the duration of one-lung ventilation is more than one hour.

          -  subjects with more than twenty years old.

        Exclusion Criteria:

          -  subjects with past history of pneumothorax, asthma

          -  Age under 20, more than 70 years.

          -  Patients with ischemic heart disease, valvular heart disease

          -  patients with hemodynamic unstability
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sangmin M. Lee, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Samsung Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Won Ho Kim, MD</last_name>
    <role>Study Director</role>
    <affiliation>Samsung Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>135-710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 16, 2012</study_first_submitted>
  <study_first_submitted_qc>February 27, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 28, 2012</study_first_posted>
  <last_update_submitted>December 24, 2013</last_update_submitted>
  <last_update_submitted_qc>December 24, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 25, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Samsung Medical Center</investigator_affiliation>
    <investigator_full_name>Sangmin M. Lee</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>one lung ventilation</keyword>
  <keyword>gas exchange</keyword>
  <keyword>inverse-ratio ventilation</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

